Hanson DC - Search Results

1

Tremelimumab (CP-675,206), a cytotoxic T lymphocyte associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer.

Ribas A, Hanson DC, Noe DA, Millham R, Guyot DJ, Bernstein SH, Canniff PC, Sharma A, Gomez-Navarro J. Ribas A, et al. Among authors: hanson dc. Oncologist. 2007 Jul;12(7):873-83. doi: 10.1634/theoncologist.12-7-873. Oncologist. 2007. PMID: 17673618 Free article. Review.

2

Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J, Lepple-Wienhues A, Gutman GA, Grissmer S, Cahalan MD, Chandy KG. Nguyen A, et al. Among authors: hanson dc. Mol Pharmacol. 1996 Dec;50(6):1672-9. Mol Pharmacol. 1996. PMID: 8967992

3

UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activation.

Hanson DC, Nguyen A, Mather RJ, Rauer H, Koch K, Burgess LE, Rizzi JP, Donovan CB, Bruns MJ, Canniff PC, Cunningham AC, Verdries KA, Mena E, Kath JC, Gutman GA, Cahalan MD, Grissmer S, Chandy KG. Hanson DC, et al. Br J Pharmacol. 1999 Apr;126(8):1707-16. doi: 10.1038/sj.bjp.0702480. Br J Pharmacol. 1999. PMID: 10372812 Free PMC article.

4

Dynamic aspects of antibody structure.

Schumaker VN, Phillips ML, Hanson DC. Schumaker VN, et al. Among authors: hanson dc. Mol Immunol. 1991 Dec;28(12):1347-60. doi: 10.1016/0161-5890(91)90037-k. Mol Immunol. 1991. PMID: 1749384 Review. No abstract available.

5

Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.

Grissmer S, Nguyen AN, Aiyar J, Hanson DC, Mather RJ, Gutman GA, Karmilowicz MJ, Auperin DD, Chandy KG. Grissmer S, et al. Among authors: hanson dc. Mol Pharmacol. 1994 Jun;45(6):1227-34. Mol Pharmacol. 1994. PMID: 7517498

6

CD4-CD8- T cells from mice with collagen arthritis display aberrant expression of type l K+ channels.

Grissmer S, Hanson DC, Natoli EJ, Cahalan MD, Chandy KG. Grissmer S, et al. Among authors: hanson dc. J Immunol. 1990 Oct 1;145(7):2105-9. J Immunol. 1990. PMID: 1975826

7

Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins.

Aiyar J, Withka JM, Rizzi JP, Singleton DH, Andrews GC, Lin W, Boyd J, Hanson DC, Simon M, Dethlefs B, et al. Aiyar J, et al. Among authors: hanson dc. Neuron. 1995 Nov;15(5):1169-81. doi: 10.1016/0896-6273(95)90104-3. Neuron. 1995. PMID: 7576659 Free article.

8

CP-123,369: a potent, orally active immunosuppressive agent.

Koch K, Hanson DC, Newborg MF, Cooper K, Fouda HG, Biehl ML, Shepard RM, Donovan CB, Biggers MS, Ramchandani M, et al. Koch K, et al. Among authors: hanson dc. Inflamm Res. 1995 Aug;44 Suppl 2:S183-4. doi: 10.1007/BF01778322. Inflamm Res. 1995. PMID: 8548388 No abstract available.

9

Ion channel modulation as a drug discovery target in inflammatory diseases.

Hanson DC, Koch K. Hanson DC, et al. Inflamm Res. 1996 Sep;45(9):435-7. doi: 10.1007/BF02252312. Inflamm Res. 1996. PMID: 8891752 No abstract available.

10

The C-32 triacetyl-L-rhamnose derivative of ascomycin: a potent, orally active macrolactone immunosuppressant.

Koch K, Newborg MF, Hanson DC, Cooper K, Shepard RM, Biehl ML, Biggers MS, Ramchandani M, Schulte G, Snyder JR, et al. Koch K, et al. Among authors: hanson dc. J Med Chem. 1995 Apr 14;38(8):1255-8. doi: 10.1021/jm00008a001. J Med Chem. 1995. PMID: 7537331 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page